Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 62332-207

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 62332-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlo 10 160mg

Label for Amlodipine and Valsartan tablets, USP, showing a strength of 10 mg/160 mg. The film-coated tablets come in a 30-count package. The label indicates prescription use only and is manufactured by Alembic Pharmaceuticals Inc. Additional text states each tablet contains 13.9 mg of amlodipine besylate USP, equivalent to 10 mg amlodipine and 160 mg valsartan USP. Storage and handling instructions are also provided.*

FDA Label Image

Amlovalsartanl 10 320mg

Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg film-coated tablets. The label from Alembic Pharmaceuticals Inc. displays the NDC number 62332-208-30. The package contains 30 tablets for oral use and is marked Rx only. Additional text includes dosage information and storage instructions.*

FDA Label Image

Amlovalsartanl 5 160mg

Label for Amlodipine and Valsartan Tablets, USP 5 mg / 160 mg, film-coated oral tablets manufactured by Alembic Pharmaceuticals Inc. The package contains 30 tablets. Includes dosing information and storage instructions, with barcode and NDC 62332-205-30 visible.*

FDA Label Image

Amlovalsartanl 5 320mg

Label for Amlodipine and Valsartan 5 mg/320 mg film-coated tablets by Alembic Pharmaceuticals Inc. The label includes the NDC 62332-207-30, dosage strength, quantity of 30 tablets, and manufacturer information. It features storage instructions, warnings, and a barcode.*

FDA Label Image

Amlovalsartanl Figur1

A line graph showing the probability of achieving systolic blood pressure below 140 mmHg at week 8, plotted against baseline systolic blood pressure (mmHg). The graph compares four groups: Amlodipine and Valsartan Tablets USP 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, with probabilities decreasing as baseline systolic blood pressure increases.*

FDA Label Image

Amlovalsartanl Figur2

Line graph showing the probability of achieving diastolic blood pressure below 90 mmHg at week 8, plotted against baseline diastolic blood pressure (DBP) from 95 to 110 mmHg. The graph compares Amlodipine and Valsartan Tablets USP 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo groups.*

FDA Label Image

Figure 3 (Amlovalsartanl Figure3)

A line graph depicting the probability of achieving systolic blood pressure below 130 mmHg at week 8 versus baseline systolic blood pressure (SBP) in mmHg. The graph compares multiple groups including Amlodipine and Valsartan tablets (10/320 mg), Valsartan 320 mg, Amlodipine 10 mg, and placebo, showing decreasing probabilities with increasing baseline SBP.*

FDA Label Image

Figure 4 (Amlovalsartanl Figure4)

A line graph showing the probability of achieving diastolic blood pressure below 80 mmHg at week 8. The graph compares Amlodipine and Valsartan tablets (10/320 mg), Valsartan 320 mg, Amlodipine 10 mg, and placebo, plotted against baseline diastolic blood pressure (DBP) ranging from 95 to 110 mmHg.*

FDA Label Image

Amlovalsartanl Str1

Chemical structure diagram showing molecular formulas with chlorine, sulfuric acid group, and other components. The specific active ingredients are not labeled on the image, but it likely depicts components relevant to the product Amlodipine and Valsartan.*

FDA Label Image

Amlovalsartanl Str2

Chemical structure diagram of the active ingredient amlodipine, as depicted in the image. The structure shows detailed atomic connections and molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.